Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21,113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tomographic analysis, CLEM: general discussion.
Al-Otaibi N, Baatsen P, Bhella D, Brescia R, Bullough P, Daum B, de Bruin R, Frank R, Kühlbrandt W, López-Iglesias C, McLaren M, Menday R, Morrissey F, Mullick D, Paris G, Parker A, Russo C, Saibil H, Scheres SHW, Shah A, Smith C, Thompson R, Thorn A, Zanetti G, Zhao J. Al-Otaibi N, et al. Among authors: smith c. Faraday Discuss. 2022 Nov 8;240(0):142-151. doi: 10.1039/d2fd90060b. Faraday Discuss. 2022. PMID: 36282233 No abstract available.
Pushing the limits in single particle cryo-EM: general discussion.
Bakker SE, Bhella D, Brescia R, Bullough P, Clare DK, Daum B, Frank RAW, Gold VAM, Jackson Hirst I, Kühlbrandt W, Lu P, McLaren M, Menday R, Muench SP, Rauschenbach S, Russo CJ, Saibil H, Scheres SHW, Shah AR, Smith C, Torpey J, Zanetti G. Bakker SE, et al. Among authors: smith c. Faraday Discuss. 2022 Nov 8;240(0):312-322. doi: 10.1039/d2fd90063g. Faraday Discuss. 2022. PMID: 36285779 No abstract available.
Sample preparation in single particle cryo-EM: general discussion.
Al-Otaibi N, Aminian J A, Anane RF, Baatsen P, Bakker SE, Bergeron J, Bharadwaj A, Bhella D, Braun T, Brescia R, Bullough P, Clare DK, Daum B, Esser TK, Farinas Lucas IDM, Frank RAW, Gold VAM, Harrison PJ, Hirst IJ, Klebl DP, Kühlbrandt W, Morton C, Muench SP, Nakasone M, Russo CJ, Saibil HR, Scheres SHW, Sehrawat V, Shah AR, Smith C, Thompson RF, Thorn A, Zanetti G. Al-Otaibi N, et al. Among authors: smith c. Faraday Discuss. 2022 Nov 8;240(0):81-100. doi: 10.1039/d2fd90059a. Faraday Discuss. 2022. PMID: 36278863 No abstract available.
Adaptations of bone and bone vasculature to muscular stretch training.
Eazer J, Barsoum M, Smith C, Hotta K, Behnke B, Holmes C, Caldwell J, Ghosh P, Reid-Foley E, Park H, Delp M, Muller-Delp J. Eazer J, et al. Among authors: smith c. JBMR Plus. 2024 Jan 4;8(3):ziad019. doi: 10.1093/jbmrpl/ziad019. eCollection 2024 Mar. JBMR Plus. 2024. PMID: 38741608 Free PMC article.
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600mutated melanoma.
Embaby A, Huijberts SCFA, Wang L, Leite de Oliveira R, Rosing H, Nuijen B, Sanders J, Hofland I, van Steenis C, Kluin RJC, Lieftink C, Smith CG, Blank CU, van Thienen JV, Haanen JBAG, Steeghs N, Opdam FL, Beijnen JH, Huitema ADR, Bernards R, Schellens JHM, Wilgenhof S. Embaby A, et al. Among authors: smith cg. Clin Cancer Res. 2024 May 13. doi: 10.1158/1078-0432.CCR-23-3171. Online ahead of print. Clin Cancer Res. 2024. PMID: 38739109
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK.
Gould RL, McDermott CJ, Thompson BJ, Rawlinson CV, Bursnall M, Bradburn M, Kumar P, Turton EJ, White DA, Serfaty MA, Graham CD, McCracken LM, Goldstein LH, Al-Chalabi A, Orrell RW, Williams T, Noad R, Baker I, Faull C, Lambert T, Chhetri SK, Ealing J, Hanratty A, Radunovic A, Gunawardana N, Meadows G, Gorrie GH, Young T, Lawrence V, Cooper C, Shaw PJ, Howard RJ; COMMEND Collaboration Group. Gould RL, et al. Lancet. 2024 May 9:S0140-6736(24)00533-6. doi: 10.1016/S0140-6736(24)00533-6. Online ahead of print. Lancet. 2024. PMID: 38735299 Free article.
21,113 results
You have reached the last available page of results. Please see the User Guide for more information.